Departments of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Stine Linding Andersen in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Peter Laurberg in
Google Scholar
PubMed
[ 2 ], and this may well lead to inadequate iodine intake among pregnant women because there is an increase in the need for iodine during pregnancy [ 3 , 4 ]. Thus, in recent years there has been much focus on the potential need for individual intake
Centre for Endocrine and Diabetes Sciences, Department of Medicine, Cardiff University School of Medicine, Cardiff, UK
Search for other papers by Peter Taylor in
Google Scholar
PubMed
Search for other papers by Sandip Bhatt in
Google Scholar
PubMed
Search for other papers by Ravi Gouni in
Google Scholar
PubMed
Search for other papers by Jonathan Quinlan in
Google Scholar
PubMed
Search for other papers by Tony Robinson in
Google Scholar
PubMed
What Is Known about This Topic • The prevalence of hyperthyroidism in pregnancy has been estimated to range between 0.1 and 1% [ 1 , 2 , 3 , 4 , 5 ] and if untreated or poorly treated there is an increased risk of adverse outcomes including
Search for other papers by Sara Donato in
Google Scholar
PubMed
NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal
Search for other papers by Helder Simões in
Google Scholar
PubMed
NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal
Unidade de Investigação em Patobiologia Molecular, Instituto Português de Oncologia de Lisboa, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
than differentiated thyroid cancer; There are scarce data about malignant SO evolution during pregnancy. Novel Insight Pregnancy may represent a stimulus for malignant SO growth in patients with previous biochemical evidence of
Search for other papers by Suvi Turunen in
Google Scholar
PubMed
Search for other papers by Marja Vääräsmäki in
Google Scholar
PubMed
Search for other papers by Maarit Leinonen in
Google Scholar
PubMed
Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden
Search for other papers by Mika Gissler in
Google Scholar
PubMed
Search for other papers by Tuija Männistö in
Google Scholar
PubMed
Search for other papers by Eila Suvanto in
Google Scholar
PubMed
Introduction Thyroid dysfunction affects up to 5–7% of all pregnancies [ 1 ]. Hypothyroidism in pregnant women is common with a prevalence of about 2-3%, and the prevalence of undiagnosed subclinical hypothyroidism in pregnancy is 3–15% [ 2
Institut National de la Recherche Médicale, UMR U895, Université Nice-Sophia Antipolis, Nice, France
Search for other papers by Françoise Brucker-Davis in
Google Scholar
PubMed
Search for other papers by Patricia Panaïa-Ferrari in
Google Scholar
PubMed
Search for other papers by Jocelyn Gal in
Google Scholar
PubMed
Institut National de la Recherche Médicale, UMR U895, Université Nice-Sophia Antipolis, Nice, France
Search for other papers by Patrick Fénichel in
Google Scholar
PubMed
Search for other papers by Sylvie Hiéronimus in
Google Scholar
PubMed
Introduction The thyroid hormone economy changes profoundly during pregnancy to accommodate maternal and fetal needs [ 1 ]. The main factors involved are the βHCG secretion by the placenta (with its stimulatory effect on maternal thyroid), the
Search for other papers by Kris Poppe in
Google Scholar
PubMed
Search for other papers by Alicja Hubalewska-Dydejczyk in
Google Scholar
PubMed
Search for other papers by Peter Laurberg in
Google Scholar
PubMed
Search for other papers by Roberto Negro in
Google Scholar
PubMed
Search for other papers by Francesco Vermiglio in
Google Scholar
PubMed
Search for other papers by Bijay Vaidya in
Google Scholar
PubMed
Introduction The prevalence of hyperthyroidism in pregnancy ranges between 0.1 and 1% [ 1 ]. The most common cause of hyperthyroidism in pregnancy is Graves’ disease (GD), occurring in about 85% of cases. Gestational transient thyrotoxicosis
Search for other papers by Roberto Negro in
Google Scholar
PubMed
Search for other papers by Roberto Attanasio in
Google Scholar
PubMed
Search for other papers by Enrico Papini in
Google Scholar
PubMed
Search for other papers by Rinaldo Guglielmi in
Google Scholar
PubMed
Search for other papers by Franco Grimaldi in
Google Scholar
PubMed
Search for other papers by Vincenzo Toscano in
Google Scholar
PubMed
Search for other papers by Dan Alexandru Niculescu in
Google Scholar
PubMed
Search for other papers by Diana Loreta Paun in
Google Scholar
PubMed
Search for other papers by Catalina Poiana in
Google Scholar
PubMed
Introduction An increasing number of studies focusing on thyroid disease and pregnancy have been published over the last decades. Such interest has been driven by at least 2 factors: the relevant number of women suffering from thyroid disease
Search for other papers by John Lazarus in
Google Scholar
PubMed
Search for other papers by Rosalind S. Brown in
Google Scholar
PubMed
Search for other papers by Chantal Daumerie in
Google Scholar
PubMed
Search for other papers by Alicja Hubalewska-Dydejczyk in
Google Scholar
PubMed
Search for other papers by Roberto Negro in
Google Scholar
PubMed
Search for other papers by Bijay Vaidya in
Google Scholar
PubMed
Introduction Subclinical hypothyroidism (SCH) in pregnancy is defined by a serum thyroid-stimulating hormone (TSH) concentration higher than the upper limit of the pregnancy-related reference range associated with a normal serum thyroxine [T 4
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Stine Linding Andersen in
Google Scholar
PubMed
Search for other papers by Louise Kolding Sørensen in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Anne Krejbjerg in
Google Scholar
PubMed
Search for other papers by Margrethe Møller in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Peter Laurberg in
Google Scholar
PubMed
Introduction Population median urinary iodine concentration (UIC) is the recommended method to assess iodine status [ 1 ]. UIC in pregnancy is extensively studied and adequate maternal iodine intake is of major concern [ 2 , 3 , 4
London School of Hygiene and Tropical Medicine, London
Search for other papers by Peter N. Taylor in
Google Scholar
PubMed
Search for other papers by Bijay Vaidya in
Google Scholar
PubMed
Introduction Hyperthyroidism in pregnancy is a serious condition, resulting in increased risk of adverse obstetric outcomes including miscarriage, stillbirth, pre-term birth and intra-uterine growth restriction [ 1 ]. Its management is complex